Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5385)
IDEXX LABORATORIES INC /DE (IDXX)
Erickson Michael G — Executive Vice President
Shares
689
Price
$629.09
Total Value
$433.44K
Shares Held After
12,733
% of Holdings
5.1%
IDEXX LABORATORIES INC /DE (IDXX)
Erickson Michael G — Executive Vice President
Shares
2,694
Price
$628.22
Total Value
$1.69M
Shares Held After
13,422
% of Holdings
16.7%
IDEXX LABORATORIES INC /DE (IDXX)
Erickson Michael G — Executive Vice President
Shares
1,288
Price
$626.26
Total Value
$806.62K
Shares Held After
16,116
% of Holdings
7.4%
IDEXX LABORATORIES INC /DE (IDXX)
Erickson Michael G — Executive Vice President
Shares
204
Price
$625.24
Total Value
$127.55K
Shares Held After
17,404
% of Holdings
1.2%
IDEXX LABORATORIES INC /DE (IDXX)
Erickson Michael G — Executive Vice President
Shares
456
Price
$623.76
Total Value
$284.43K
Shares Held After
17,608
% of Holdings
2.5%
IDEXX LABORATORIES INC /DE (IDXX)
Vandebroek Sophie V. — Director
Shares
519
Price
$628.56
Total Value
$326.22K
Shares Held After
648
% of Holdings
44.5%
IDEXX LABORATORIES INC /DE (IDXX)
Vandebroek Sophie V. — Director
Shares
945
Price
$628.65
Total Value
$594.07K
Shares Held After
1,167
% of Holdings
44.7%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
2
Price
$70.13
Total Value
$140.26
Shares Held After
111,312
% of Holdings
0.0%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
2,811
Price
$69.29
Total Value
$194.77K
Shares Held After
111,314
% of Holdings
2.5%
Gemini Therapeutics, Inc. (GMTX)
Franchi Jean M. — Chief Financial Officer
Shares
4,075
Price
$62.86
Total Value
$256.15K
Shares Held After
78,424
% of Holdings
4.9%
Bio-Techne Corporation (TECH)
Herr Amy E. — Director
Shares
1,976
Price
$59.10
Total Value
$116.79K
Shares Held After
200
% of Holdings
90.8%
NATIONAL RESEARCH CORP (NRC)
HARRISON SHANE R — EVP & Chief Financial Officer
Shares
8,000
Price
$12.27
Total Value
$98.16K
Shares Held After
8,000
% of Holdings
100.0%
Neumora Therapeutics, Inc. Common Stock (NMRA)
Milligan Michael Lee — Title: Chief Financial Officer & Principal Accounting Officer
Shares
1,436
Price
$3.56
Total Value
$5.12K
Shares Held After
21,034
% of Holdings
6.4%
Neumora Therapeutics, Inc. Common Stock (NMRA)
BERNS PAUL L — Director
Shares
9,819
Price
$3.51
Total Value
$34.46K
Shares Held After
7,395,185
% of Holdings
0.1%
Neumora Therapeutics, Inc. Common Stock (NMRA)
Pinto Joshua — President
Shares
5,967
Price
$3.54
Total Value
$21.09K
Shares Held After
57,783
% of Holdings
9.4%
Neumora Therapeutics, Inc. Common Stock (NMRA)
Aurora Daljit Singh — Title: Chief Operating and Development Officer
Shares
6,165
Price
$3.56
Total Value
$21.92K
Shares Held After
82,770
% of Holdings
6.9%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Shares
609
Price
$489.46
Total Value
$298.08K
Shares Held After
49,018
% of Holdings
1.2%
Scholar Rock Holding Corp (SRRK)
Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Shares
7,989
Price
$46.53
Total Value
$371.71K
Shares Held After
106,929
% of Holdings
7.0%
Scholar Rock Holding Corp (SRRK)
Ho Junlin — GENERAL COUNSEL
Shares
9,580
Price
$46.53
Total Value
$445.74K
Shares Held After
241,545
% of Holdings
3.8%
Scholar Rock Holding Corp (SRRK)
Parlavecchio Caryn — CHRO
Shares
9,035
Price
$46.53
Total Value
$420.38K
Shares Held After
169,087
% of Holdings
5.1%
Scholar Rock Holding Corp (SRRK)
Marantz Jing L. — CHIEF MEDICAL OFFICER
Shares
4,157
Price
$46.53
Total Value
$193.42K
Shares Held After
126,012
% of Holdings
3.2%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Webster Brian Daniel — Director
Shares
93
Price
$27.18
Total Value
$2.53K
Shares Held After
379,786
% of Holdings
0.0%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Webster Brian Daniel — Director
Shares
3,272
Price
$26.29
Total Value
$86.04K
Shares Held After
379,879
% of Holdings
0.9%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Webster Brian Daniel — Director
Shares
11,635
Price
$25.39
Total Value
$295.46K
Shares Held After
383,151
% of Holdings
2.9%
Inotiv, Inc. (NOTV)
Leasure Robert Jr. — Director
Shares
16,810
Price
$0.30
Total Value
$4.96K
Shares Held After
1,256,215
% of Holdings
1.3%
Inotiv, Inc. (NOTV)
Sagartz John E — Chief Strategy Officer
Shares
2,119
Price
$0.29
Total Value
$616.21
Shares Held After
735,697
% of Holdings
0.3%
Inotiv, Inc. (NOTV)
Taylor Beth A. — Chief Financial Officer
Shares
2,888
Price
$0.29
Total Value
$845.90
Shares Held After
145,480
% of Holdings
1.9%
ENSIGN GROUP, INC (ENSG)
Shaw Daren — Director
Shares
1,000
Price
$213.43
Total Value
$213.43K
Shares Held After
23,726
% of Holdings
4.0%
Karyopharm Therapeutics Inc. (KPTI)
Poulton Stuart — EVP, Chief Development Officer
Shares
378
Price
$8.63
Total Value
$3.26K
Shares Held After
99,429
% of Holdings
0.4%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Ambrose Kristen — SVP & Chief Accounting Officer
Shares
1,557
Price
$489.46
Total Value
$762.09K
Shares Held After
8,388
% of Holdings
15.7%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
3,541
Price
$53.11
Total Value
$188.06K
Shares Held After
287,788
% of Holdings
1.2%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
26,952
Price
$52.69
Total Value
$1.42M
Shares Held After
291,329
% of Holdings
8.5%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
16,616
Price
$51.42
Total Value
$854.44K
Shares Held After
318,281
% of Holdings
5.0%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
21,858
Price
$50.32
Total Value
$1.10M
Shares Held After
334,897
% of Holdings
6.1%
Twist Bioscience Corp (TWST)
Green Paula — SVP of Human Resources
Shares
39,404
Price
$52.40
Total Value
$2.06M
Shares Held After
126,041
% of Holdings
23.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Atkinson Edward Morrow III — EVP, Chief Technical Ops. Off.
Shares
2,031
Price
$489.46
Total Value
$994.09K
Shares Held After
21,544
% of Holdings
8.6%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Biller Jonathan — EVP and Chief Legal Officer
Shares
2,476
Price
$489.46
Total Value
$1.21M
Shares Held After
16,992
% of Holdings
12.7%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
4,321
Price
$28.26
Total Value
$122.12K
Shares Held After
105,211
% of Holdings
3.9%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
5,679
Price
$27.50
Total Value
$156.20K
Shares Held After
109,532
% of Holdings
4.9%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bunnage Mark E. — EVP, Chief Scientific Officer
Shares
2,437
Price
$489.46
Total Value
$1.19M
Shares Held After
9,668
% of Holdings
20.1%
Ceribell, Inc. (CBLL)
Parvizi Josef — Director
Shares
1,300
Price
$20.00
Total Value
$26.00K
Shares Held After
746,352
% of Holdings
0.2%
JOHNSON & JOHNSON (JNJ)
Broadhurst Vanessa — EVP, Global Corp Affairs
Shares
6,197
Price
$243.39
Total Value
$1.51M
Shares Held After
23,003
% of Holdings
21.2%
JOHNSON & JOHNSON (JNJ)
REED JOHN C — EVP, Innovative Medicine, R&D
Shares
2,283
Price
$243.00
Total Value
$554.77K
Shares Held After
10,658
% of Holdings
17.6%
JOHNSON & JOHNSON (JNJ)
REED JOHN C — EVP, Innovative Medicine, R&D
Shares
29,927
Price
$243.00
Total Value
$7.27M
Shares Held After
12,941
% of Holdings
69.8%
JOHNSON & JOHNSON (JNJ)
REED JOHN C — EVP, Innovative Medicine, R&D
Shares
21,721
Price
$243.00
Total Value
$5.28M
Shares Held After
12,941
% of Holdings
62.7%
JOHNSON & JOHNSON (JNJ)
Wolk Joseph J — Exec VP, CFO
Shares
24,961
Price
$242.68
Total Value
$6.06M
Shares Held After
14,000
% of Holdings
64.1%
JOHNSON & JOHNSON (JNJ)
Wolk Joseph J — Exec VP, CFO
Shares
33,386
Price
$242.75
Total Value
$8.10M
Shares Held After
38,961
% of Holdings
46.1%
JOHNSON & JOHNSON (JNJ)
Wolk Joseph J — Exec VP, CFO
Shares
12,066
Price
$242.87
Total Value
$2.93M
Shares Held After
38,961
% of Holdings
23.6%
JOHNSON & JOHNSON (JNJ)
Wolk Joseph J — Exec VP, CFO
Shares
19,241
Price
$242.99
Total Value
$4.68M
Shares Held After
38,961
% of Holdings
33.1%
JOHNSON & JOHNSON (JNJ)
Swanson James D. — EVP, CIO
Shares
20,521
Price
$242.70
Total Value
$4.98M
Shares Held After
25,698
% of Holdings
44.4%
Showing 2501–2550 of 5385 transactions (page 51 of 108)